Insertion of an Intrauterine Device (IUD) After Medical Abortion
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00621543|
Recruitment Status : Completed
First Posted : February 22, 2008
Results First Posted : July 8, 2011
Last Update Posted : July 14, 2011
The purpose of this study is to determine the expulsion and continuation rate of an intruterine device (IUD) placed immediately after medical abortion.
Our hypothesis is that immediate-placement of an IUD after completed medical abortion will have a similar expulsion and continuation rate to traditional placement (4-6 weeks after pregnancy).
|Condition or disease||Intervention/treatment||Phase|
|Intrauterine Device Expulsion Medical Abortion Induced Abortion||Device: IUD insertion [Copper T-380A or Levonorgestrel (intrauterine system) IUS]||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||120 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Insertion of an IUD After Medical Abortion|
|Study Start Date :||March 2006|
|Actual Primary Completion Date :||May 2008|
|Actual Study Completion Date :||September 2008|
Experimental: Observation- All subjects
Women choosing intra-uterine contraception after medical abortion.
Device: IUD insertion [Copper T-380A or Levonorgestrel (intrauterine system) IUS]
When a subject has chosen a method of intra-uterine contraception and has agreed to participate in the study, she will have the intra-uterine device of her choice inserted according to the Food and Druga Administration (FDA) instructions.
Other Name: IUD insertion icludes the insertion of either the Copper T-380A or Levonorgestrel (intrauterine system) IUS
- Percentage of Women With Expulsion of an Intrauterine Device (IUD) Placed After Medical Abortion. [ Time Frame: Three months ]
- Percentage of Women Continuing IUD Use at 3 Months [ Time Frame: 3 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00621543
|United States, Massachusetts|
|Boston Medical Center|
|Boston, Massachusetts, United States, 02118|
|United States, Utah|
|University of Utah|
|Salt Lake City, Utah, United States, 84112|
|Principal Investigator:||Sarah J Betstadt, MD||Boston University|
|Study Director:||Lynn Borgatta, MD, MPH||Boston University|